Arcus Biosciences, Inc. (RCUS) Total liabilities 2017–2025
Arcus Biosciences, Inc. (RCUS) total liabilities at each fiscal year-end, per SEC filings.
$508.0MFY2025 · since FY2017: $36.6M → $508.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $508.0M | -23.6% |
| FY2024 | $665.0M | +5.1% |
| FY2023 | $633.0M | -8.0% |
| FY2022 | $688.0M | -8.3% |
| FY2021 | $750.4M | +178.0% |
| FY2020 | $270.0M | +587.6% |
| FY2019 | $39.3M | -1.8% |
| FY2018 | $40.0M | +9.2% |
| FY2017 | $36.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice